Zink STADA 25 mg Tablets 90 Pieces
High-dose zinc support for immunity, skin health, and cellular protection
Category: Supplements
Purpose: Supports immune function, skin health, and protection against oxidative stress
What It Is
Zink STADA 25 mg Tablets is a dietary supplement providing 25 mg of zinc per tablet in the form of zinc citrate, a highly bioavailable form that is efficiently absorbed by the body. Zinc is an essential trace element involved in numerous enzymatic processes and vital for maintaining overall health.
This formulation supports immune system function, skin integrity, and antioxidant defense, helping protect cells from oxidative stress. It also contributes to the maintenance of healthy hair, nails, bones, and normal metabolic processes.
✅ Key Benefits
- Supports normal immune system function
- Helps maintain healthy skin, hair, and nails
- Contributes to protection of cells from oxidative stress
- Supports normal metabolism of fats, proteins, and carbohydrates
- High bioavailability zinc citrate formula
Use & Dosage
- Take 1 tablet daily with water
- Preferably during a meal
- Swallow whole without chewing
- Do not exceed the recommended daily intake
⚠️ Safety & Precautions
- Do not exceed recommended daily dose
- Avoid combining with other zinc supplements
- Food supplements should not replace a balanced diet
- Keep out of reach of children
- Use under medical supervision if necessary
Product Details
Form: Tablets
Active Ingredients: Zinc (25 mg as zinc citrate)
Target Group: Adults with increased zinc needs or deficiency risk
Pack Size: 90 tablets
Buy Zink STADA 25 mg Tablets 90 Pieces
Support your immune system, skin health, and overall vitality with high-dose zinc citrate—available now at pharmeu.
SEO Keywords:
zink stada 25 mg tablets, zinc citrate supplement 90 tablets, zinc immune support supplement, zinc tablets for skin hair nails, high dose zinc 25 mg, zinc deficiency supplement, antioxidant zinc tablets, zinc metabolism support, stada zinc tablets 90 pcs, zinc supplement daily use
.
